This month in Greater Los Angeles life sciences: #AtaraBiotherapeutics reports that the FDA accepted its biologics license application for tab-cel®. @ImmunityBio receives expanded FDA approval for Anktiva in bladder cancer. #PasadenaBioCollaborativeIncubator receives a transformational building gift from the Morton La Kretz family. #TORLBioTherapeutics strengthens its leadership team with the recent appointments of its chief financial officer and chief medical officer. Subscribe to receive the next newsletter in your inbox: bit.ly/3WFbOLh

Our Bay Area CEO Summit is in full swing, with life science leaders gathering at Ram's Gate Winery in Sonoma for a day of insightful discussions and meaningful connections. Join the conversation and share your favorite moments by using #BiocomCEOSummit.

This week in San Diego life sciences: @UCSDExtStudies is offering a pharma clinical, regulatory and compliance course. #FirstTracksBiotherapeutics secures $200 million through a private placement. #PrimroseBio launches two RNA polymerases for high-quality, low-cost mRNA production. @VividionRx expands clinical development of VVD-214 with a phase 2 combination study in first-line treatment of advanced colorectal cancer. Subscribe to receive the next newsletter in your inbox: bit.ly/4iqn5b1

Biocom member @thaumatec Tech Group now offers end-to-end medical device software services, from regulatory guidance and development to post-market maintenance and modernization. Explore its four integrated services: bit.ly/4jBGTMg

In this month’s Policy & Advocacy Newsletter, we cover the recent roundtable with Bay Area Congressman Kevin Mullin, 12 Biocom supported state bills signed into law, CMS's new finalized GLOBE Model, two proposed fees for facilities regulated under CUPA programs in Los Angeles and more. Read the full newsletter: bit.ly/40yIJCC

Orange County leaders across medtech and life sciences are invited to join @BiocomInstitute for its upcoming town hall, to review key findings from the OC MedTech Workforce Skills Assessment. Attendees will explore current and emerging regional workforce needs, discuss actionable takeaways for employers and connect directly with workforce partners shaping local talent pipelines. Reserve your seat: bit.ly/4zJ7QSN

Biocom member Informa brings Finance & Accounting for Bioscience West to San Diego, December 7-8, to support executives in navigating the unique challenges of emerging, small and mid-sized biotech companies. Explore capital strategy, commercial readiness, AI-driven finance and more with bioscience finance leaders. Register: bit.ly/4skmoFX

As capital markets evolve, life science finance leaders face new decisions around IPO readiness, M&A and private funding paths. Join Biocom on November 4 at 4 p.m. PST in San Diego for "The New Capital Playbook: IPO, M&A & the Changing Path to Growth". This session convenes life science finance leaders for a candid analysis of today’s financing and transaction environment. The conversation will explore IPO readiness, M&A, capital planning, strategic positioning, risk management and the infrastructure needed to withstand scrutiny from investors, buyers and auditors. Registration is reserved exclusively for life science financial executives. Secure your seat today: bit.ly/4yTWKtH

Meet the industry leaders sharing valuable insights and candid perspectives at our Greater LA CEO Summit on October 27. Don't miss your chance to attend. Register today: bit.ly/4zLkVer #BiocomCEOSummit

Beyond AI and digital health, Servier is also seeking the platforms and tools behind drug discovery, delivery and manufacturing. Applications are being accepted through November 6. Priority areas include: 🔹 Oligonucleotide platforms: Novel monomers, ASO design and conjugates, targeted saRNAs, neuronal delivery and manufacturing 🔹 Antibody, ADC, and small molecule innovation: Bispecific and multispecific formats, novel ADC linkers, molecular glues, bifunctional molecules and RNA-targeting small molecules 🔹 Drug delivery: Prodrugs, polymer-drug conjugates, targeted LNPs and exosomes 🔹 Advanced biological models: iPSC systems, patient-derived models, organoids and organ-on-chip platforms 🔹 Screening, imaging and biomarkers: High-throughput antibody screening, spatial multiomics, in vivo ASO biodistribution imaging, ctDNA and methylation assays and single-cell ATAC 🔹 Sample prep and manufacturing: Laser capture microdissection, continuous synthesis, photochemistry, electrochemistry and inline analytics Meetings are by application only, and companies must be available to attend in person on December 9: bit.ly/4zeeOiK

For 25 years, Joe Panetta @Emeritus_Biocom led Biocom as president and CEO, helping grow it into a leading voice for the life science industry in California and beyond. Today, he continues to contribute to that legacy as president emeritus. Earlier this year, @SenBrianJones presented Joe with a Resolution recognizing his service. We’re proud to celebrate his lasting impact. #CALeg

Don't miss out! Join the Life Science & Tech Consultants Association on Wednesday, October 21 at Yale Labs in Seattle for AI in Drug Manufacturing: Are We Ready for Industry 5.0? Hear directly from technical leaders at @pfizer and @JustEvotecBio as they unpack the real impact of AI on production workflows, predictive decision-making and the future workforce. Grab your ticket before registration closes: bit.ly/4yYpd1Z

Meet the industry leaders providing valuable insights at our Bay Area CEO Summit this Friday, October 23. Don't miss your chance to attend. Register today: bit.ly/4yxvbpL #BiocomCEOSummit #LifeScienceEvents

It's #NewMemberMonday! 🎓 @AUGradSchool provides higher education, research and innovation partnerships designed to empower students and turn their research into actionable, real-world impact. 🧬 #HexemBio combines AI with synthetic human yolk sac models to uncover early regenerative biology, developing therapies for blood stem cell rejuvenation to improve bone marrow transplant outcomes and extend the average healthy lifespan. 💉 #Orlance develops the needle-free MACH-1 platform to deliver DNA and RNA vaccines and immunotherapies directly into the skin without cold-chain storage requirements. 🧬 @SharkToothBio develops targeted therapeutics for Charcot-Marie-Tooth disease type 1A, focusing on PMP22 gene duplication and protein overproduction to restore peripheral nerve myelination and function. ❄️ @untillabs develops reversible cryopreservation technology that pauses molecular motion without ice formation to keep donor organs viable longer. 💊 #XseerPharmaceuticals provides FDA-registered manufacturing services that meet current good manufacturing practice standards and 503B outsourcing.

Advance your expertise in clinical development and regulatory compliance. @UCSDExtStudies’ Pharma Clinical, Regulatory, and Compliance course explores clinical trials, FDA requirements, pharmacovigilance and pharmaceutical quality standards. Learn more: bit.ly/4s3OQfb

Last call to receive personalized presentation coaching that helps you capitalize on your unique presentation style and make the most of the skills you already have. @BiocomInstitute has partnered with @LabtoLeader to offer Present to Influence, a presentation coaching workshop led by Catriona Breider. Participants can choose between an in-person session in San Diego or an interactive virtual session. Each cohort is capped at five participants to provide direct, one-on-one coaching in a structured and supportive environment. Attendees will deliver a video-recorded practice presentation, receive structured feedback and gain practical tools to manage nervous energy, connect with an audience and turn complex data into insightful narratives. In-person | San Diego • When: October 21 | 8:30 a.m. – 12:30 p.m. PDT • Where: SD Tech by Alexandria • Register: bit.ly/4yzwm85 Virtual | Interactive Workshop • When: October 28 | 8:30 a.m. – 12:30 p.m. PDT • Where: Zoom • Register: bit.ly/4i7U1X9

This week in Bay Area life sciences: 🏛️ @BenitecBio announces an FDA regulatory update for the BB-301 pivotal study. 💼 @OmniAbTech highlights partner pipeline progress and introduced the OmniTides platform at its Investor & Analyst Day. 🏆 @RayTherapeutics celebrates the 2026 Nobel Prize by recognizing foundational discoveries in optogenetics. 👁️ @surrozen receives FDA clearance of its IND application for SZN-8141 for the treatment of diabetic macular edema. Subscribe to receive the next newsletter in your inbox: bit.ly/40rlR8a

This week in San Diego life sciences: @Erasca receives FDA Fast Track designation for Pan-RAS molecular glue ERAS-0015 for the treatment of metastatic pancreatic adenocarcinoma. @exthymic secures up to $25 million through an ARPA-H contract to advance its hospital-based cell therapy production prototype. @iambic_ai files for a $135 million IPO to advance its cancer drug pipeline. @PersephoneBio will provide 50,000 free doses of infant and toddler synbiotics. Subscribe to receive the next newsletter in your inbox: bit.ly/4iqn5b1

Scaling molecular diagnostics from development to commercial production? Join Biocom member @Roche for a webinar exploring manufacturing challenges, regulatory requirements, supplier reliability and strategies for successful commercialization. Learn more and register: bit.ly/4inbufg

331 AI- and machine learning-enabled medical device submissions were cleared for marketing in the U.S. in 2025, up 41% from 2024, according to data highlighted in Biocom’s 2026 Life Science Economic Impact Report. Diagnostics are becoming faster, smarter and increasingly actionable. Explore the report: bit.ly/4uXG7uN